Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37446296 | PubTator, text mining | PubMed |
| Assessing a biomarker's ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study. | PLoS One | 2023 | 37432960 | PubTator, text mining | PubMed |
| A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma. | Cancer Gene Ther | 2023 | 37420093 | PubTator, text mining | PubMed |
| Classification and characterisation of extracellular vesicles-related tuberculosis subgroups and immune cell profiles. | J Cell Mol Med | 2023 | 37409682 | PubTator, text mining | PubMed |
| Beyond Pattern Recognition: TLR2 Promotes Chemotaxis, Cell Adhesion, and Migration in THP-1 Cells. | Cells | 2023 | 37408259 | PubTator, text mining | PubMed |
| Single-cell sequencing analysis of peripheral blood in patients with moyamoya disease. | Orphanet J Rare Dis | 2023 | 37400835 | PubTator, text mining | PubMed |
| Emerging diversity in extracellular vesicles and their roles in cancer. | Front Oncol | 2023 | 37397375 | PubTator, text mining | PubMed |
| Protein Corona Attenuates the Targeting of Antitumor Sialyl Lewis X-Decorated Liposomes to Vascular Endothelial Cells under Flow Conditions. | Pharmaceutics | 2023 | 37376203 | PubTator, text mining | PubMed |
| Survey of Dietary Habits and Physical Activity in Japanese Patients with Non-Obese Non-Alcoholic Fatty Liver Disease. | Nutrients | 2023 | 37375668 | PubTator, text mining | PubMed |
| Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. | Life (Basel) | 2023 | 37374110 | PubTator, text mining | PubMed |
| Advances in Therapeutic Applications of Extracellular Vesicles. | Int J Nanomedicine | 2023 | 37346366 | PubTator, text mining | PubMed |
| Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. | Sci Rep | 2023 | 37344505 | PubTator, text mining | PubMed |
| Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein. | Mol Cell Proteomics | 2023 | 37343697 | PubTator, text mining | PubMed |
| Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization. | Adv Sci (Weinh) | 2023 | 37340602 | PubTator, text mining | PubMed |
| Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia. | iScience | 2023 | 37332612 | PubTator, text mining | PubMed |
| Human amygdala involvement in Alzheimer's disease revealed by stereological and dia-PASEF analysis. | Brain Pathol | 2023 | 37331354 | PubTator, text mining | PubMed |
| Identification of aryl hydrocarbon receptor as a barrier to HIV-1 infection and outgrowth in CD4+ T cells. | Cell Rep | 2023 | 37310858 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection. | J Virol | 2023 | 37306574 | PubTator, text mining | PubMed |
| The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host-Pathogen Interactions. | Int J Mol Sci | 2023 | 37298569 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects. | Int J Mol Sci | 2023 | 37298466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=17